Document Detail


Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion.
MedLine Citation:
PMID:  12218579     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Immunohistochemistry (IHC) is an important adjunctive test in diagnostic surgical pathology. We studied the clinical significance and outcomes in performing IHC on cases with a previous diagnosis of cancer who are coming to the Fox Chase Cancer Center (FCCC), a National Cancer Institute designated National Comprehensive Cancer Center (NCCC), for treatment and/or second opinion. We reviewed all the outside surgical pathology slide review cases seen at the FCCC for 1998 and 1999 in which IHC was performed. Cases were divided into the following: confirmation of outside diagnoses without and with prior IHC performed by the outside institution (groups A and B, respectively) and cases with a significant change in diagnosis without and with prior IHC performed by the outside institution (groups C and D, respectively). During 1998 and 1999, 6678 slide review cases were reviewed at the FCCC with an overall significant change in diagnosis in 213 cases (3.2%). IHC was performed on 186 of 6678 (2.7%) slide review cases with confirmation of the outside diagnosis in 152 (81.7%) cases and a significant change in diagnosis in 34 (18.3%) cases. Patient follow-up was obtained in 32 of 34 (94.1%) cases with a significant change in diagnosis (groups C and D), which confirmed the correctness of our diagnosis in 26 of 27 cases (96%; in five cases follow-up was inconclusive). We repeated the identical antibodies performed by the outside institutions in group D (37 antibodies) and group B (133 antibodies) with different results in 48.6% and 13.5%, respectively (overall nonconcordance 21.2%). In group D additional antibody tests beyond that performed by the outside institution were needed in 88.8% of cases to make a change of diagnosis. In the setting of a NCCC, reperforming and/or performing IHC on cases with a previous diagnosis of cancer is not a duplication of effort or misuse of resources. Repeating and/or performing IHC in this setting is important in the care and management of patients with cancer.
Authors:
R Wesley Wetherington; Harry S Cooper; Tahseen Al-Saleem; Debbie S Ackerman; Rose Adams-McDonnell; Wendy Davis; Hormoz Ehya; Arthur S Patchefsky; Joanne Suder; Nancy A Young
Related Documents :
24495259 - "review of findings in prophylactic gynaecologic specimens in lynch syndrome with liter...
8572159 - Brief communication: a possible case of melorheostosis from antiquity.
1207559 - Limitations of the nash logoscope or diagnostic slide rule.
10438689 - Mania in the geriatric patient population: a review of the literature.
20966259 - Diagnosis, treatment, and outcome of eastern box turtles (terrapene carolina carolina) ...
17569719 - Unilateral syphilitic perioptic neuritis in a patient coinfected with human immunodefic...
21923699 - Primary lymphoma of the uterus and cervix: two case reports and review of the literature.
6794299 - Atypical acute promyelocytic leukemia (m3 variant): description of two cases.
23575389 - Characteristics of non-fatal self-poisoning in sri lanka: a systematic review.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of surgical pathology     Volume:  26     ISSN:  0147-5185     ISO Abbreviation:  Am. J. Surg. Pathol.     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-09-09     Completed Date:  2002-09-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7707904     Medline TA:  Am J Surg Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1222-30     Citation Subset:  IM    
Affiliation:
Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comprehensive Health Care*
Diagnostic Errors
Health Resources
Immunohistochemistry / methods*
Neoplasms* / chemistry,  pathology,  therapy
Pathology, Clinical / methods*,  standards
Peer Review, Health Care
Quality Assurance, Health Care
Referral and Consultation*
Retrospective Studies
Tumor Markers, Biological / analysis
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of ad...
Next Document:  A case of clear cell adenocarcinoma of the müllerian duct in persistent müllerian duct syndrome: t...